1986
DOI: 10.1002/jps.2600751113
|View full text |Cite
|
Sign up to set email alerts
|

Intranasal Administration of Peptides: Nasal Deposition, Biological Response, and Absorption of Desmopressin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
56
0

Year Published

1988
1988
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 146 publications
(57 citation statements)
references
References 16 publications
1
56
0
Order By: Relevance
“…This mechanism of MCC influences the process of absorption because of the dissolved drugs in the nasal cavity which is released by both cilia and mucus 19 . It has also been observed in many studies that deposition of molecules in the anterior end of the cavity decreases MCC, leading to increase in absorption and bioavailability 20,21 . Likewise, also due to the presence of enzymes such as peptidasesExo-peptidases (mono and diamino-peptidases), which cleave the peptides at N and C terminal and endo-peptidases (serine and cysteine) cleaves the internal peptide bond, in the lumen of the nasal cavity, causes low transport of these biomolecules leading to low absorption of therapeutic molecules.…”
Section: Mechanism Of Drug Absorption Through Indd Routementioning
confidence: 90%
“…This mechanism of MCC influences the process of absorption because of the dissolved drugs in the nasal cavity which is released by both cilia and mucus 19 . It has also been observed in many studies that deposition of molecules in the anterior end of the cavity decreases MCC, leading to increase in absorption and bioavailability 20,21 . Likewise, also due to the presence of enzymes such as peptidasesExo-peptidases (mono and diamino-peptidases), which cleave the peptides at N and C terminal and endo-peptidases (serine and cysteine) cleaves the internal peptide bond, in the lumen of the nasal cavity, causes low transport of these biomolecules leading to low absorption of therapeutic molecules.…”
Section: Mechanism Of Drug Absorption Through Indd Routementioning
confidence: 90%
“…Enhancing mechanisms include decrease in mucociliary clearance, reduction of mucus viscosity or elasticity, inhibition of enzyme activity, opening of tight junctions, and solubilization or stabilization of the drug molecule [11][12][13][14][15][16][17][18][19][20][21][22][23][24]. Mucociliary clearance can be defined as combined actions of the mucus layer and the cilia, which is an important factor in the physiological defence of the respiratory tract against inhaled hazardous particles [13].…”
Section: Limitations Of Nasal Deliverymentioning
confidence: 99%
“…The use of bioadhesive excipients in the formulations is an approach to overcome rapid mucociliary clearance. Depositing the formulation in the anterior, less ciliated part of the nasal cavity may also reduce the clearance and thus improved the absorption [17,18]. Metabolic enzymes in the nasal mucosa may also limit the bioavailability of some drugs particularly peptides and proteins [19].…”
Section: Limitations Of Nasal Deliverymentioning
confidence: 99%
“…Their humidifying effect is convenient and useful, since many allergic and chronic diseases are often connected with crusts and drying of mucous membranes. Microbiological stability, irritation and allergic rhinitis are the major drawbacks associated with the water based dosage forms because the required preservatives impair mucociliary function and the reduced chemical stability of the dissolved drug substance and the short residence time of the formulation in the nasal cavity are major disadvantages of liquid formulations 20 . The several types dosage forms available in liquid form are described below.…”
Section: Nasal Drug Delivery System Dosage Formsmentioning
confidence: 99%